PA8454301A1 - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number: PA8454301A1
Authority: PA; Panama
Prior art keywords: soltrilized; sertralina; compositions; sertraline; solubility
Prior art date: 1997-07-01

Application number

PA19988454301A

Other languages

English (en)

Spanish (es)

Inventor

Ravi Mysore Shanker

James Blair West

Dwayne Thomas Friessen

Scott Max Herbing

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-29

Publication date

2000-09-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8454301(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-29 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-09-29 Publication of PA8454301A1 publication Critical patent/PA8454301A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PA19988454301A 1997-07-01 1998-06-29 Composiciones solubilizadas de sertralina PA8454301A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
PA8454301A1 true PA8454301A1 (es)	2000-09-29

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PA19988454301A PA8454301A1 (es)	1997-07-01	1998-06-29	Composiciones solubilizadas de sertralina

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (fr)
JP (1)	JP2000514100A (fr)
KR (1)	KR100366373B1 (fr)
CN (1)	CN1261794A (fr)
AP (1)	AP1192A (fr)
AR (3)	AR015917A1 (fr)
AU (1)	AU742535B2 (fr)
BG (1)	BG103918A (fr)
BR (1)	BR9810739A (fr)
CA (1)	CA2290974C (fr)
CO (1)	CO4940495A1 (fr)
DZ (1)	DZ2548A1 (fr)
EA (1)	EA002481B1 (fr)
HN (1)	HN1998000102A (fr)
HR (1)	HRP980377A2 (fr)
HU (1)	HUP0002236A3 (fr)
ID (1)	ID23429A (fr)
IL (1)	IL133076A (fr)
IS (1)	IS5260A (fr)
MA (1)	MA24587A1 (fr)
NO (1)	NO996520L (fr)
OA (1)	OA11243A (fr)
PA (1)	PA8454301A1 (fr)
PE (1)	PE97199A1 (fr)
PL (1)	PL337804A1 (fr)
SK (1)	SK181099A3 (fr)
TN (1)	TNSN98124A1 (fr)
TR (1)	TR199903297T2 (fr)
TW (1)	TW550087B (fr)
UA (1)	UA67741C2 (fr)
UY (1)	UY25071A1 (fr)
WO (1)	WO1999001120A1 (fr)
YU (1)	YU68299A (fr)
ZA (1)	ZA985708B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003518485A (ja)	1999-12-23	2003-06-10	ファイザー・プロダクツ・インク	向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
WO2002017918A2 (fr)	2000-08-30	2002-03-07	Pfizer Products Inc.	Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) *	2007-03-12	2015-03-06	디에스엠 아이피 어셋츠 비.브이.	미용 조성물
EP2520299A1 (fr) *	2009-12-29	2012-11-07	Kowa Co., Ltd.	Composition pharmaceutique solide pour l'administration orale
EP2520300A4 (fr) *	2009-12-29	2013-05-08	Kowa Co	Composition pharmaceutique pour administration orale
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) *	2022-05-20	2022-08-12	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
EP0415612B1 (fr) *	1989-08-30	1993-11-10	Pfizer Inc.	Utilisation de la sertraline pour le traitement des dépendances aux produits chimiques
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/fr not_active Expired - Fee Related
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/fr not_active Application Discontinuation
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/fr not_active Withdrawn
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/fr active
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
MA24587A1 (fr)	1998-12-31
UY25071A1 (es)	2000-12-29
OA11243A (en)	2003-07-24
UA67741C2 (uk)	2004-07-15
AR015917A1 (es)	2001-05-30
EP0999829A1 (fr)	2000-05-17
WO1999001120A1 (fr)	1999-01-14
PE97199A1 (es)	1999-10-05
IL133076A (en)	2003-12-10
HUP0002236A3 (en)	2003-12-29
EA199900962A1 (ru)	2000-08-28
CA2290974A1 (fr)	1999-01-14
AU742535B2 (en)	2002-01-03
BG103918A (en)	2000-07-31
TR199903297T2 (xx)	2000-07-21
PL337804A1 (en)	2000-09-11
DZ2548A1 (fr)	2003-02-08
AR040280A2 (es)	2005-03-23
JP2000514100A (ja)	2000-10-24
YU68299A (sh)	2002-06-19
ZA985708B (en)	2000-01-10
IS5260A (is)	1999-11-19
CO4940495A1 (es)	2000-07-24
BR9810739A (pt)	2000-09-12
KR20010013365A (fr)	2001-02-26
HUP0002236A2 (hu)	2003-08-28
AR040279A2 (es)	2005-03-23
CA2290974C (fr)	2004-04-27
AP9801280A0 (en)	1998-06-30
TW550087B (en)	2003-09-01
SK181099A3 (en)	2000-07-11
NO996520L (no)	2000-02-29
HN1998000102A (es)	1999-01-08
IL133076A0 (en)	2001-03-19
TNSN98124A1 (fr)	2005-03-15
NO996520D0 (no)	1999-12-28
EA002481B1 (ru)	2002-06-27
AP1192A (en)	2003-07-23
KR100366373B1 (ko)	2003-01-14
ID23429A (id)	2000-04-20
HRP980377A2 (en)	1999-04-30
AU7544898A (en)	1999-01-25
CN1261794A (zh)	2000-08-02

Publication	Publication Date	Title
ES2235311T8 (es)	2011-05-13	Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
AU134374S (en)	1998-07-17	Container for wipes or the like
FR2676173B1 (fr)	1993-08-13	Composition cosmetique contenant un agent alcalinisant sans odeur.
GB9717905D0 (en)	1997-10-29	Lipid-containing compositions and uses thereof
ID23807A (id)	2000-05-11	Metoda dan komposisi yang mengandung-semen untuk digunakan dalam bawah tanah
ZA995601B (en)	2000-09-27	Water-soluble pharmaceutical composition in an ionic complex and the use thereof.
ES2115071T3 (es)	1998-06-16	Agente para la aplicacion por via transdermica, que contiene 3-ceto-desogestrel.
PA8454301A1 (es)	2000-09-29	Composiciones solubilizadas de sertralina
BR9407040A (pt)	1996-03-12	Uso de um anti-oxidante e solução para preservação de órgãos
BR9610930A (pt)	1999-12-21	Composição depilatória incluindo uma quantidade funcional de um agente tixoitrópico, e, uso da quantidade funcional de um agente tixotrópico.
DE68923950D1 (de)	1995-09-28	Stabilisierungsmittel für Dispersionen von anorganischem Pulver in öligem Material.
BR9811958B1 (pt)	2010-08-24	uso de um absorvedor de uv derivado de bis(resorcinil)triazina e formulaÇço cosmÉtica compreendendo o mesmo.
BR9713043A (pt)	2000-04-11	Composição para limpeza de superfìcies rìgidas.
NO961651D0 (no)	1996-04-25	Antifryssammensetning og vandig fluid som inneholder sammensetningen
ES2179508T3 (es)	2003-01-16	Composicion cosmetica que comprende una amida y nuevas amidas.
ECSP982572A (es)	1999-01-26	Composiciones solubilizadas de sertralina
EA200000112A1 (ru)	2000-10-30	Новая композиция
ZA99849B (en)	2000-08-03	Lipid mixtures and their use.
GB2337518B (en)	2003-10-08	Dissolution inhibitor of chemically amplified photoresist and chemically amplified photoresist composition containing the same
NO985079L (no)	1998-10-30	Eksplosiv formulering
ES2163091T3 (es)	2002-01-16	Composicion detergente.
NL1007839A1 (nl)	1998-06-23	Formulering en gebruik.
MX9205556A (es)	1993-04-01	Mejoras en composiciones novedosas que comprenden pentafluoroetano y monoclorodifluorometano.
DK0457127T3 (da)	1997-01-06	Spermicidt belægningsmiddel
ES2113765T3 (es)	1998-05-01	Dimaleato de n,n-dietil-8,8-dipropil-2-azaespiro(4.5)decano-2-propanamina.